Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Diane 35 plus finasteride is more effective for treating hirsutism.

Spironolactone plus finasteride works better for treating hirsutism.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Acupressure improves quality of life in PCOS patients.

Flutamide reduces hair growth better but has more side effects.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Coloring white hair before IPL treatment effectively helps remove it.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.